JPRN-UMIN000019354已完成未知
Efficacy and safety of insulin glargine 300 U/ml versus 100 U/ml in type 2 diabetic patients treated with basal insulin plus oral hypoglycemic agents - Efficacy and safety of insulin glargine 300 U/ml versus 100 U/ml in type 2 diabetic patients treated with basal insulin plus oral hypoglycemic agents
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- patients injecting bolus insulin and/or GLP-1 receptor agonist - patients expected to have other antidiabetic agents added, changed, or increased/decreased in dosage during the next 6 months - difficulty to perform self-monitoring blood glucose - Patients with severe hepatic, renal, and/or cardiac disease - Patients with hypersentitivity to the agents used in the current study - Patients who are pregnant, breast-feeding or may become pregnant - Patients who are judged by the investigator to be inappropriate for this study for any other reason.
研究者
相似试验
已完成
不适用
Efficacy and safety of insulin glargine 300 U/ml versus 100 U/ml in type 2 diabetic patients treated with basal insulin plus GLP-1 receptor agonisttype 2 diabetesJPRN-UMIN000019353Shiraiwa Medical Clinic30
已完成
不适用
Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Degludec in Patients with Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring ProfilesdiabetesJPRN-UMIN000031044Minamiosaka Hospital30
招募中
不适用
Comparison of efficacy and safety of insulin glargine U-100/lixisenatide and insulin degludec/liraglutide in type 2 diabetes patientstype 2 Diabetes mellitusJPRN-UMIN000047518Minami Osaka Hospital36
招募中
不适用
Efficacy and safety of once daily insulin glargine therapy for people with type 2 diabetes inadequately controlled with DPP4 inhibitor and several OADsType 2 DiabetesJPRN-UMIN000007375Tokyo Medical University100
尚未招募
不适用
A clinical trial to study the effect of insulin glargine injection given earlier during diabetic ketoacidosis (DKA) along with regular treatment as compared to regular treatment alone in children with Type-1 DiabetesCTRI/2022/11/047612Aster Intramural funding